Nov 19, 2025 08:55AM Piper Sandler on IO Biotech (IOBT): 'We Remain Buyers'

Nov 14, 2025 08:06AM IO Biotech, Inc. (IOBT) Tops Q3 EPS by 22c

Nov 7, 2025 09:02AM IO Biotech presents preclinical data for cancer vaccine candidates

Sep 29, 2025 04:40PM TD Cowen Downgrades IO Biotech (IOBT) to Hold

Sep 29, 2025 11:54AM H.C. Wainwright Downgrades IO Biotech (IOBT) to Neutral

Sep 29, 2025 07:06AM IO BIOTECH delays drug application after FDA feedback, cuts workforce by 50%

Sep 23, 2025 08:11AM IO Biotech gets late-breaking abstract for cancer vaccine trial at ESMO

Aug 14, 2025 04:12PM IO Biotech, Inc. (IOBT) Misses Q2 EPS by 3c

Aug 11, 2025 04:26PM IO Biotech (IOBT) PT Lowered to $4 at Morgan Stanley

May 14, 2025 05:09PM IO Biotech, Inc. (IOBT) Misses Q1 EPS by 3c

Apr 25, 2025 01:02PM IO Biotech (IOBT) Presents New Data Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170

Mar 5, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on IO Biotech (IOBT)

Mar 4, 2025 04:18PM IO Biotech (IOBT) Reports 2024 Business Highlights

Feb 4, 2025 08:05AM IO Biotech (IOBT) Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112

Jan 27, 2025 11:45AM Jefferies Reiterates Buy Rating on IO Biotech (IOBT), PT $8, 'A positive PFS could also provide sig upside potential'

Dec 20, 2024 08:05AM IO Biotech (IOBT) secures up to €57.5 million in debt financing from the European Investment Bank

Nov 12, 2024 07:14AM IO Biotech, Inc. (IOBT) Misses Q3 EPS by 7c

Nov 7, 2024 10:00AM IO Biotech (IOBT) Reports IO102-IO103 in Combination with KEYTRUDA Demonstrates Promising Activity and Durability in First-line Treatment of Patients with Metastatic Lung Cancer in Phase 2 IOB-022 Stu

Sep 16, 2024 07:47AM Piper Sandler Reiterates Overweight Rating on IO Biotech (IOBT)

Sep 9, 2024 12:25PM Morgan Stanley on IO Biotech (IOBT): 'We are encouraged by continued meaningful benefits in a second indication (melanoma lead indication)'

Sep 3, 2024 08:51AM IO Biotech (IOBT) PT Lowered to $8 at Jefferies

Sep 3, 2024 07:42AM Piper Sandler Reiterates Overweight Rating on IO Biotech (IOBT)

Sep 3, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on IO Biotech (IOBT)

Aug 30, 2024 04:06PM IO Biotech (IOBT) Provides Updates on Phase 3 Trial of IO102-IO103 plus KEYTRUDA

Aug 13, 2024 08:45AM IO Biotech, Inc. (IOBT) Tops Q2 EPS by 3c